Lai I-Li, You Jeng-Fu, Chern Yih-Jong, Tsai Wen-Sy, Chiang Jy-Ming, Hsieh Pao-Shiu, Hung Hsin-Yuan, Hsu Yu-Jen
Division of Colon and Rectal Surgery, Chang Gung Memorial Hospital, Linkou, No.5, Fu-Hsing Street, Guei-Shan, Tao-Yuan, Taiwan.
World J Surg Oncol. 2021 Apr 13;19(1):116. doi: 10.1186/s12957-021-02223-4.
Radical resection is associated with good prognosis among patients with cT1/T2Nx rectal cancer. However, still some of the patients experienced cancer recurrence following radical resection. This study tried to identify the postoperative risk factors of local recurrence and distant metastasis separately.
This retrospective, single-center study comprised of 279 consecutive patients from Linkou branch of Chang Gung Memorial Hospital in 2005-2016 with rectal adenocarcinoma, pT1/T2N0M0 at distance from anal verge ≤ 8cm, who received curative radical resection.
The study included 279 patients with pT1/pT2N0 mid-low rectal cancer with median follow-up of 73.5 months. Nineteen (6.8%) patients had disease recurrence in total. Nine (3.2%) of them had local recurrence, and fourteen (5.0%) of them had distant metastasis. Distal resection margin < 0.9 (cm) (hazard ratio = 4.9, p = 0.050) was the risk factor of local recurrence. Preoperative carcinoembryonic antigen (CEA) ≥ 5 ng/mL (hazard ratio = 9.3, p = 0.0003), lymph node yield (LNY) < 14 (hazard ratio = 5.0, p = 0.006), and distal resection margin < 1.4cm (hazard ratio = 4.0, p = 0.035) were the risk factors of distant metastasis.
For patients with pT1/pT2N0 mid-low rectal cancer, current multidisciplinary treatment brings acceptable survival outcome. Insufficient distal resection margin attracted the awareness of risk factors for local recurrence and distant metastasis as a foundation for future research.
根治性切除与cT1/T2Nx期直肠癌患者的良好预后相关。然而,仍有一些患者在根治性切除后出现癌症复发。本研究试图分别确定局部复发和远处转移的术后危险因素。
这项回顾性单中心研究纳入了2005年至2016年来自长庚纪念医院林口分院的279例连续性直肠腺癌患者,这些患者距肛缘≤8cm,pT1/T2N0M0,接受了根治性切除。
该研究纳入了279例pT1/pT2N0期的中低位直肠癌患者,中位随访时间为73.5个月。共有19例(6.8%)患者出现疾病复发。其中9例(3.2%)出现局部复发,14例(5.0%)出现远处转移。远端切缘<0.9(cm)(风险比=4.9,p=0.050)是局部复发的危险因素。术前癌胚抗原(CEA)≥5 ng/mL(风险比=9.3,p=0.0003)、淋巴结获取量(LNY)<14(风险比=5.0,p=0.006)以及远端切缘<1.4cm(风险比=4.0,p=0.035)是远处转移的危险因素。
对于pT1/pT2N0期的中低位直肠癌患者,目前的多学科治疗带来了可接受的生存结果。远端切缘不足作为局部复发和远处转移的危险因素引起了关注,为未来研究奠定了基础。